Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
      • Software
      • Artificial Intelligence
      • Cybersecurity
      • Usability and Human Factors Engineering
      • Clinical
        • Evaluation
        • Investigation
          • 🗄 Drafts
          • R-015-005 Investigator's Brochure Legit.Health_acne
          • ADS TLD DAO 2025
          • AIHS4 2025
          • BI 2024
          • COVIDX EVCDAO 2022
          • DAO Derivación O 2022
          • DAO Derivación PH 2022
          • IDEI 2023
          • MC EVCDAO 2019
          • PH 2024
          • SAN 2024
        • R-TF-015-008 Clinical development plan
      • Commissioning
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Pricing
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Product Verification and Validation
  • Clinical
  • Investigation

Investigation

🗃️ 🗄 Drafts

4 items

📄️ R-015-005 Investigator's Brochure Legit.Health_acne

Introduction

🗃️ ADS TLD DAO 2025

2 items

🗃️ AIHS4 2025

2 items

🗃️ BI 2024

3 items

🗃️ COVIDX EVCDAO 2022

3 items

🗃️ DAO Derivación O 2022

3 items

🗃️ DAO Derivación PH 2022

3 items

🗃️ IDEI 2023

3 items

🗃️ MC EVCDAO 2019

3 items

🗃️ PH 2024

3 items

🗃️ SAN 2024

3 items

Previous
R-TF-015-011 State of the Art Legit.Health Plus
Next
🗄 Drafts
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)